Hassan-sponsored bill aims to cut prescription drug costs

A bill co-sponsored by U.S. Senator Maggie Hassan, D-New Hampshire, aims to reduce the cost of prescription drugs. Hassan said the bill is a bipartisan effort to reduce generic drug costs and get to market faster by making generic drug companies better equipped to compete with larger companies. According to Georgetown University, the average prescription drug cost for all adults is about $177 per year. This rises to more than $400 per year for people between the ages of 65 and 79. Hassan said she was optimistic the bill would take the necessary steps to become a reality for American families. and we hope that as we build support for the bill, it will cross the finish line in the coming months,” Hassan said. “What’s really important here is that we do everything we can to improve the competition.” about this question.

A bill co-sponsored by U.S. Senator Maggie Hassan, D-New Hampshire, aims to reduce the cost of prescription drugs.

Hassan said the bill is a bipartisan effort to lower the costs of generic drugs and get them to market faster by making generic drug companies better equipped to compete with big companies.

According to Georgetown University, the average prescription drug cost for all adults is about $177 per year. This rises to more than $400 per year for people aged 65 to 79.

Hassan said she was optimistic the bill would take the necessary steps to become a reality for American families.

“The House has passed similar legislation, so that’s a good sign, and we hope that as we build support for the bill, it will cross the finish line in the coming months,” Hasan said. “What’s really important here is that we do everything we can to improve the competition.”

Hassan said there should also be a focus on allowing Medicare to negotiate prescription drug prices to help save consumers money, but both sides of the aisle appear to be split on this issue. .

Source link

About Alex S. Crone

Check Also

Calls for fillers to be prescription only to stop the “conveyor belt” of procedures

DERMAL fillers are a popular choice for cosmetic procedures in the UK. But groups have …